
Pulmonary oedema, hypotension, asystole, bradycardia and convulsions have been reported. In very rare cases rhabdomyolysis, metabolic acidosis, hyperkalaemia or cardiac failure, sometimes with fatal outcome, have been observed when propofol was administered at dosages in excess of 4 mg/kg/h for sedation in the intensive care unit.
Reports from off-label use of Propofol for induction of anaesthesia in neonates indicates that cardio-respiratory depression may occur if the paediatric dose regimen is applied.
Local: The local pain which may occur during the induction phase of propofol injection anaesthesia can be minimised by the co-administration of lidocaine (see Dosage & Administration) and by the use of the larger veins of the forearm and antecubital fossa. Thrombosis and phlebitis are rare. Accidental clinical extravasation and animal studies showed minimal tissue reaction. Intra-arterial injection in animals did not induce local tissue effects.
View ADR Monitoring Form